Diabetes key to transplant success, research finds

Better management of diabetes could have highly beneficial outcomes for lung transplant patients.

(Medical Xpress)—Better management of diabetes could dramatically improve outcomes for lung transplant patients, with new research showing that those without diabetes lived twice as long as transplant recipients with the disease.

In a study presented at ENDO 2013 - the Annual Meeting and Expo of the American Endocrine Society - researchers led by Dr Kathryn Hackman of Monash University analysed over 10 years. They found that those with diabetes, whether diagnosed before or after the operation, had a five-fold greater risk of dying.

Data were examined from 386 lung transplants performed at The Alfred Hospital between 2001 and 2010. Analysis showed that the average survival period for patients with diabetes was five years, compared with 10 years for those who did not have the condition.

Dr Hackman, who is completing her PhD at Monash University and is an endocrinologistat The Alfred, said that causes of death were the same for all lung transplant recipients, irrespective of their diabetes status.

"The patients with diabetes were not dying of stroke, cardiovascular disease or other diabetes-related illnesses. The main cause of death in all was a known as bronchiolitis obliterans, which is a form of of the transplanted organ," Dr Hackman said.

"This suggests that diabetes could be affecting the transplanted lungs and causing them to fail earlier."

Dr Hackman said that diabetes screening had previously not been a routine aspect of post-transplant care, but that this approach is now being rethought.

"Only 30 per cent of lung transplant recipients survive beyond ten years. It was thought that the effects of diabetes, which manifest in the longer term, would not be significant to the health of these patients. However, our research suggests that diabetes is not a side issue, it's a critical issue for lung transplant patients," Dr Hackman said.

"We have the knowledge and the means to easily and effectively manage . It's quite possible that we could significantly improve the outlook for lung transplant patients."

add to favorites email to friend print save as pdf

Related Stories

Vitamin D deficiency linked to lung transplant rejection

Oct 18, 2010

Vitamin D deficiency is associated with a significant increase in lung transplant rejection, according to research conducted at Loyola University Health System (LUHS). These data were presented Monday at The American Society ...

Recommended for you

How does DPP-4 inhibition affect liver function?

Jan 27, 2015

(HealthDay)—Dipeptidyl peptidase-4 (DPP-4) inhibition may attenuate hepatic steatosis and insulin resistance induced by the Western diet (WD) through hepatic lipid remodeling and modulation of hepatic mitochondrial ...

Team shows why wound healing is impaired in diabetics

Jan 26, 2015

One of the most troubling complications of diabetes is its effect on wound healing. Roughly 15 percent of diabetics will suffer from a non-healing wound in their lifetime. In some cases, these open ulcers on the skin lead ...

Progress in diabetes drug delivery

Jan 22, 2015

A drug therapy for diabetes treatment is being developed by an international research team led by WA scientists, which combines an existing anti-diabetic drug with bile acids to improve the drug's delivery ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.